Capra Biosciences

About:

Capra Biosciences develops bioreactor technology that turns byproducts and waste into valuable bio-based materials.

Website: https://www.caprabiosciences.com

Twitter/X: caprabio

Top Investors: IndieBio, Alumni Ventures, SOSV, The E14 Fund, Asymmetry Ventures

Description:

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels.

Total Funding Amount:

$12.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Alexandria, Virginia, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)caprabiosciences.com

Founders:

Andrew Magyar, Elizabeth Onderko

Number of Employees:

1-10

Last Funding Date:

2024-07-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai